BACKGROUND: Manganese deposition was suspected in a pediatric patient who received long-term total parenteral nutrition. T1-weighted magnetic resonance images revealed high intensity areas in the globus pallidus. This study was designed to clarify if these abnormal findings were related to manganese deposition and clinical neurological manifestations. METHODS: Whole-blood manganese concentrations were measured during manganese supplementation to total parenteral nutrition and after 5 months without manganese. Magnetic resonance images were also examined on each occasion and compared with the blood level of manganese. RESULTS: The whole-blood manganese level during supplementation was 135 micrograms/L (normal range 14.6 +/- 4.7 micrograms/L), whereas the level was 20 micrograms/L after a manganese-free period of 5 months. Accompanied with normalization of manganese level, abnormal high intensity lesions in the globus pallidus on T1-weighted images also disappeared. No neurological manifestation related to the high manganese level was recognized. CONCLUSIONS: It is probable that the high manganese level was elicited by manganese supplementation to total parenteral nutrition. This high manganese condition was confirmed by the measurement of whole-blood manganese level, which was associated with the abnormal high intensity lesions on T1-weighted magnetic resonance images.
BACKGROUND:Manganese deposition was suspected in a pediatric patient who received long-term total parenteral nutrition. T1-weighted magnetic resonance images revealed high intensity areas in the globus pallidus. This study was designed to clarify if these abnormal findings were related to manganese deposition and clinical neurological manifestations. METHODS: Whole-blood manganese concentrations were measured during manganese supplementation to total parenteral nutrition and after 5 months without manganese. Magnetic resonance images were also examined on each occasion and compared with the blood level of manganese. RESULTS: The whole-blood manganese level during supplementation was 135 micrograms/L (normal range 14.6 +/- 4.7 micrograms/L), whereas the level was 20 micrograms/L after a manganese-free period of 5 months. Accompanied with normalization of manganese level, abnormal high intensity lesions in the globus pallidus on T1-weighted images also disappeared. No neurological manifestation related to the high manganese level was recognized. CONCLUSIONS: It is probable that the high manganese level was elicited by manganese supplementation to total parenteral nutrition. This high manganese condition was confirmed by the measurement of whole-blood manganese level, which was associated with the abnormal high intensity lesions on T1-weighted magnetic resonance images.
Authors: N Kamata; N Oshitani; R Oiso; T Kawachiya; M Inagawa; D Kawashima; M Iimuro; M Sogawa; Y Jinno; K Watanabe; S Nakamura; K Higuchi; T Matsumoto; T Arakawa Journal: Dig Dis Sci Date: 2003-05 Impact factor: 3.199
Authors: Allison Kupsco; Marco Sanchez-Guerra; Chitra Amarasiriwardena; Kasey J M Brennan; Guadalupe Estrada-Gutierrez; Katherine Svensson; Lourdes Schnaas; Ivan Pantic; Martha María Téllez-Rojo; Andrea A Baccarelli; Robert O Wright Journal: Environ Int Date: 2019-03-05 Impact factor: 9.621
Authors: R M Bowler; C-L Yeh; S W Adams; E J Ward; R E Ma; S Dharmadhikari; S A Snyder; S E Zauber; C W Wright; U Dydak Journal: Neurotoxicology Date: 2017-06-03 Impact factor: 4.294
Authors: Judy L Aschner; Adam Anderson; James Christopher Slaughter; Michael Aschner; Steven Steele; Amy Beller; Amanda Mouvery; Heather M Furlong; Nathalie L Maitre Journal: Am J Clin Nutr Date: 2015-11-11 Impact factor: 7.045